Medreich is a finished-dose manufacturer based in India. It appears in 198 regulatory filings across 11 regulators, without an active US DMF or CEP on file. Its filings concentrate with MEDSAFE (NZ), NAFDAC (NG) and EMA. Its GMP standing is certified by EMA, MHRA (UK) and CDSCO (India), among 5 authorities. Customs aggregates show $157.7M of exports covering 3,969 molecules to 49 destinations in 2025.
| Site | FDA FEI |
|---|---|
| FELTHAM, United Kingdom | Not on file |
| hoskote taluk bengaluru rural, India | Not on file |
| bengaluru 62, India | Not on file |
| BANGALORE RURAL DISTRICT, India | Not on file |
| Bengaluru Rural, India | Not on file |
| Bengaluru, India | Not on file |
2 further sites are on record.
| Regulator | Filings | GMP certificates |
|---|---|---|
| MEDSAFE (NZ) | 58 | None |
| NAFDAC (NG) | 48 | 4 |
| EMA | 27 | 6 |
| DH (HK) | 23 | None |
| ARCSA (EC) | 18 | None |
| MINSA (CR) | 8 | None |
| MHRA (UK) | None | 5 |
| CDSCO (India) | None | 4 |
| FDA (GH) | None | 2 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $24.2M | 29 |
| 2025 | Not reported | $157.7M | 49 |
| 2024 | Not reported | $169.2M | 47 |
| 2023 | Not reported | $163.4M | 58 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Medreich comes back tiered against every other supplier able to file there.
Start for free